clofarabine has been researched along with Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XB; Wang, S; Wang, SQ; Yu, B; Yuan, XH; Zhao, W | 1 |
| Ma, Y; Yang, J; Zhang, C; Zhu, L; Zhu, X | 1 |
| Chen, M; Chen, Z; Fan, H; Liu, R; Zhang, J | 1 |
| Fan, Z; Hou, Z; Li, Y; Tian, H; Wang, F; Xue, K; Zhao, Q; Zhu, F | 1 |
| Cros-Perrial, E; Dumontet, C; Jordheim, LP; Lefebvre-Tournier, I; Peyrottes, S; Puy, JY | 1 |
| Deng, H; Liu, B; Ma, Y; Mou, Q; Wang, D; Wang, R; Wu, C; Yan, D; Zhang, C; Zhu, X | 1 |
| Liu, H; Shi, L; Tong, G; Wang, D; Wu, J; Xu, L; Yan, D; Yu, C; Zhu, X | 1 |
| Chen, X; Lu, Y; Tu, X; Zhang, Y; Zhong, D | 1 |
| Abt, ER; Austin, WR; Bazzy, J; Cabebe, AE; Capri, JR; Czernin, J; Donahue, TR; Faull, KF; Gipson, RM; Herrmann, K; Herschman, HR; Kim, W; Lavie, A; Le, TM; Lee, JT; Phelps, ME; Poddar, S; Radu, CG; Sadeghi, S; Slavik, R; Steele, D; Taechariyakul, T; Uong, NT; Van Valkenburgh, JS; Wang, X; Wei, L; Witte, ON; Yaghoubi, SS | 1 |
| Bohannan, Z; Borthakur, G; Bueso-Ramos, C; Daver, N; Faderl, S; Garcia-Manero, G; Hosing, C; Jabbour, E; Kadia, T; Kantarjian, HM; Khoury, JD; Maduike, R; Miller, D; Patel, K; Pemmaraju, N; Ravandi, F; Sasaki, K; Verstovsek, S | 1 |
| Bagley, RG; Crawford, J; Krumbholz, R; Kurtzberg, LS; Lovett, D; Roth, S; Rouleau, C; Schmid, S; Teicher, BA; Yao, M | 1 |
| Albertioni, F; Juliusson, G; Lotfi, K; Zhenchuk, A | 1 |
| Bonate, PL; Cunningham, CC; Gaynon, P; Jeha, S; Kadota, R; Lam, GN; Razzouk, B; Rytting, M; Steinherz, P; Weitman, S | 1 |
| Cortes, J; Du, M; Faderl, S; Gandhi, V; Giles, F; Ibrahim, N; Jeha, S; Kantarjian, HM; Keating, M; Khuri, F; Kozuch, P; McLaughlin, P; O'Brien, S; Plunkett, W; Rios, MB | 1 |
| Sternberg, A | 1 |
| Cooper, T; Gandhi, V; Kantarjian, H; Plunkett, W | 1 |
| Faderl, S; Gandhi, V; Jeha, S; Kantarjian, HM; Keating, MJ; Plunkett, W | 1 |
| Arthaud, L; Bonate, PL; Cantrell, WR; Secrist, JA; Stephenson, K; Weitman, S | 1 |
5 review(s) available for clofarabine and Neoplasms
| Article | Year |
|---|---|
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Humans; Molecular Structure; Neoplasms; Pyrimidines; United States; United States Food and Drug Administration | 2021 |
Mechanisms of anti-cancer action and pharmacology of clofarabine.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neoplasms | 2009 |
Clofarabine. Bioenvision/ILEX.
Topics: Adenine Nucleotides; Animals; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Drugs, Investigational; Humans; Neoplasms; Technology, Pharmaceutical | 2003 |
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Agents; Arabinonucleosides; Child; Clofarabine; Hematologic Neoplasms; Humans; Leukemia; Lymphoproliferative Disorders; Neoplasms | 2005 |
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Drug Approval; Drug Design; Humans; Leukemia, Myeloid, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2006 |
4 trial(s) available for clofarabine and Neoplasms
| Article | Year |
|---|---|
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.
Topics: Adenine Nucleotides; Adult; Aged; Aged, 80 and over; Arabinonucleosides; Clofarabine; Cytarabine; Disease-Free Survival; DNA Methylation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms; Treatment Outcome | 2017 |
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Topics: Adenine Nucleotides; Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleosides; Biological Availability; Body Weight; Child; Child, Preschool; Clofarabine; Creatinine; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Young Adult | 2011 |
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Agents; Arabinonucleosides; Bone Marrow; Breast Neoplasms; Clofarabine; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Hematologic Neoplasms; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Liver; Lung Neoplasms; Male; Middle Aged; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2003 |
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Cohort Studies; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Models, Chemical; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms; Nucleosides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2004 |
11 other study(ies) available for clofarabine and Neoplasms
| Article | Year |
|---|---|
Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Cell Line, Tumor; Clofarabine; Drug Carriers; Floxuridine; Humans; Mice; Mucin-1; Neoplasms; Nucleosides; Tissue Distribution; Transplantation, Heterologous | 2022 |
A cocktail therapeutic strategy based on clofarabine-containing aptamer-PROTAC for enhanced cancer therapy.
Topics: Clofarabine; Combined Modality Therapy; Endonucleases; Humans; Neoplasms; Nucleosides; Oligonucleotides | 2023 |
Ultralong-Circulating and Self-Targeting "Watson-Crick A = T"-Inspired Supramolecular Nanotheranostics for NIR-II Imaging-Guided Photochemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Clofarabine; Drug Liberation; Humans; Indocyanine Green; Infrared Rays; Macromolecular Substances; Methotrexate; Mice; Neoplasms; Optical Imaging; Particle Size; Photochemotherapy; Surface Properties; Theranostic Nanomedicine; Tumor Cells, Cultured | 2020 |
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Antineoplastic Agents; Arabinonucleosides; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cladribine; Clofarabine; Humans; Limit of Detection; Neoplasms; Polyphosphates; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Vidarabine | 2017 |
A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy.
Topics: Adenine Nucleotides; Animals; Aptamers, Nucleotide; Arabinonucleosides; Cell Line, Tumor; Clofarabine; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; Humans; Mice; Nanoparticles; Neoplasms; Nucleosides; Optical Imaging; Prodrugs | 2017 |
Nucleoside Analogue-Based Supramolecular Nanodrugs Driven by Molecular Recognition for Synergistic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Clofarabine; Folic Acid; Folic Acid Antagonists; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Mice, Inbred BALB C; Mice, Nude; Molecular Dynamics Simulation; Nanoparticles; Neoplasms; Quinazolines; Rats; Thiophenes | 2018 |
A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Arabinonucleosides; Chromatography, Liquid; Clofarabine; Drug Monitoring; Humans; Leukocytes, Mononuclear; Limit of Detection; Neoplasms; Polyphosphates; Tandem Mass Spectrometry | 2014 |
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Arabinonucleosides; Biomarkers, Tumor; Cell Line, Tumor; Clofarabine; Contrast Media; Deoxycytidine Kinase; Humans; Leukemia; Mice; Neoplasms; Positron-Emission Tomography; Prodrugs; Rats | 2016 |
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
Topics: Adenine Nucleotides; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Bone Marrow Cells; Cells, Cultured; Cladribine; Clofarabine; Granulocyte-Macrophage Progenitor Cells; HT29 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Models, Biological; Neoplasms; Treatment Outcome; Vidarabine Phosphate; Xenograft Model Antitumor Assays | 2009 |
Bibliography. Current world literature. Therapeutic modalities.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Cancer Vaccines; Clofarabine; Cytokines; Epidermal Growth Factor; Glucocorticoids; Humans; Interleukin-2; Metalloporphyrins; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sirolimus | 2004 |
A tale of two drugs.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Benzenesulfonates; Clofarabine; Drug Approval; Drug Design; Humans; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2006 |